A critical advance in cancer study is arising with the use of mini-antibodies to reactivate mutated p53. This crucial cancer protector protein is frequently disabled in several types of malignancies, leading https://sb-bookmarking.com/story22070799/nanobodies-restore-p53-the-potential-hope-for-cancer-treatment